Hentges F, Geczy C L, Geczy A F, De Weck A L
Immunology. 1977 Jun;32(6):905-13.
An antiserum (anti-lymphokine globulin, ALkG) directed against highly-purified products of activated lymphocytes, inhibits normal lymphocyte transfer (NLT), immune lymphocyte transfer (ILT) and direct reactions (DR) elicited by lymph node cells from strain 2 guinea-pigs in the skin of strain Bio B recipients. When injected i.d. around the site of injection of donor cells or i.v. into Bio B guinea-pigs, ALkG partially suppressed the initial inflammatory phase associated with NLT reactions and totally abolished the flare-up phase. ALkG is directed against three newly synthesized lymphocyte products (one of them being migration inhibitory factor, MIF) which are involved in the mediation of delayed hypersensitivity reactions . Since ALkG does not contain cytotoxic antibodies against guinea-pig lymphocyte cell antigens and since its inhibitory activity is not absorbed by lymphoid cells, it is probable that the inhibition of NLT reactions is not mediated by the lysis of donor or host cells but rather by the inactivation of a soluble factor elaborated as a result of the allogeneic interaction. The injection of ALkG 2 days after the initiation of the NLT reaction only produces a partial suppression of the inflammatory response associated with the flare-up phase indicating that ALkG must be present during the first 24–48 h in order effectively to inhibit the development of the NLT reaction, possibly by blocking the action of a humoral substance mediating the flare-up reaction. These findings suggest that ALkG is capable of inhibiting some product(s) of allogeneic cell interactions not only (ALkG has previously been shown to inhibit the guinea-pig mixed leucocyte reaction by reacting with a blastogenic factor produced during the MLC reaction) but also suggesting that similar lymphocyte products may be responsible for both (NLT) an (MLC) reactivity.
一种针对活化淋巴细胞高度纯化产物的抗血清(抗淋巴细胞球蛋白,ALkG),可抑制正常淋巴细胞转移(NLT)、免疫淋巴细胞转移(ILT)以及由2系豚鼠淋巴结细胞在Bio B系受体皮肤中引发的直接反应(DR)。当在供体细胞注射部位周围皮下注射或静脉注射到Bio B系豚鼠体内时,ALkG可部分抑制与NLT反应相关的初始炎症期,并完全消除爆发期。ALkG针对三种新合成的淋巴细胞产物(其中一种是迁移抑制因子,MIF),这些产物参与迟发型超敏反应的介导。由于ALkG不包含针对豚鼠淋巴细胞细胞抗原的细胞毒性抗体,且其抑制活性不被淋巴细胞吸收,因此NLT反应的抑制可能不是由供体细胞或宿主细胞的裂解介导的,而是由同种异体相互作用产生的一种可溶性因子的失活介导的。在NLT反应开始2天后注射ALkG,仅对与爆发期相关的炎症反应产生部分抑制,这表明ALkG必须在最初的24 - 48小时内存在,才能有效抑制NLT反应的发展,可能是通过阻断介导爆发反应的体液物质的作用。这些发现表明,ALkG不仅能够抑制同种异体细胞相互作用的某些产物(此前已证明ALkG通过与MLC反应期间产生的一种促有丝分裂因子反应来抑制豚鼠混合淋巴细胞反应),还表明类似的淋巴细胞产物可能是(NLT)和(MLC)反应性的原因。